<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;A16A&quot;,&quot;href&quot;:&quot;atc/A16A.md&quot;},{&quot;label&quot;:&quot;vestronidase alfa&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;VestronidaseAlfa_Qi2019_reference&quot;,&quot;label&quot;:&quot;Qi_2019_reference&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_vestronidase_alfa/VestronidaseAlfa_Qi2019_reference.md&quot;,&quot;status&quot;:&quot;extracted \u00b7 stale&quot;,&quot;css&quot;:&quot;pk-badge--green&quot;,&quot;here&quot;:false}]"></div>

# vestronidase alfa

- **generic name:** vestronidase alfa
- **ATC codes:** `A16AB18`
- **DrugBank:** [DB12366](https://go.drugbank.com/drugs/DB12366) · **PubChem:** not captured
- **groups:** approved, investigational

## About

Vestronidase alfa is an enzyme replacement therapy used to treat mucopolysaccharidosis VII, also known as Sly syndrome. It is authorised in the European Union and is used mainly for this rare metabolic disorder.

<small>Summary written by `glm-5.3-flash` from [Wikidata Q48970976](https://www.wikidata.org/wiki/Q48970976) and the WHO ATC classification and the EMA medicines list; not checked by a person.</small>

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-05 12:18 | 6:48 | 1/0/0 | 0/0/1 | 0/0/0 | 72,846/22,162 | ollama / qwen3.8:27b-mtp-q8_0 | 2 | 1/1 | 2/0 | 0 |

## popPK records

| status | detail | model | model structure | params | citation | doi |
|---|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--green">extracted</span> <span class="pk-badge pk-badge--stale">stale</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss-120b (not confirmed, agreement 0.667). Primary extraction retained.">cross-check: disputed</span><br><sub>STALE — current validate: extracted</sub><br><sub>route_to: `engineer_replication`</sub> | [Qi_2019_reference](drugs/drug_vestronidase_alfa/VestronidaseAlfa_Qi2019_reference.md) | ▶ model + simulator | 2-compartment, IV | 4 | Qi Y et al., Pharmacokinetic and Pharmacodynamic Mod…, Clinical pharmacokinetics (2019) | [10.1007/s40262-018-0721-y](https://doi.org/10.1007/s40262-018-0721-y) |

## Pharmacodynamics (PD)

| status | detail | about | model | citation | doi |
|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--red" title="re-read by einfracz:gpt-oss-120b (not confirmed, agreement 0.667). Primary extraction retained.">cross-check: disputed</span> | [Qi_2019_uCS](drugs/drug_vestronidase_alfa/pd_Qi_2019_uCS.md) | Urinary chondroitin sulfate ← vestronidase alfa · direct Emax (saturable) effect | model (no simulator) | Qi Y et al., Pharmacokinetic and Pharmacodynamic Mod…, Clinical pharmacokinetics (2019) | [10.1007/s40262-018-0721-y](https://doi.org/10.1007/s40262-018-0721-y) |
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--red" title="re-read by einfracz:gpt-oss-120b (not confirmed, agreement 0.667). Primary extraction retained.">cross-check: disputed</span> | [Qi_2019_uDS](drugs/drug_vestronidase_alfa/pd_Qi_2019_uDS.md) | Urinary dermatan sulfate ← vestronidase alfa · direct Emax (saturable) effect | model (no simulator) | Qi Y et al., Pharmacokinetic and Pharmacodynamic Mod…, Clinical pharmacokinetics (2019) | [10.1007/s40262-018-0721-y](https://doi.org/10.1007/s40262-018-0721-y) |

<details class="legend">
<summary>Status and cross-check definitions</summary>
<table><thead><tr><th>Badge</th><th>Definition</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>Human-authored reference record or exemplar.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>Accepted extraction; applicable closed-form checks passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>Generated-model predictions agree with reported reference values; not human-verified.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>Replication accepted with unresolved advisory checks.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>Incomplete, inconsistent, or implausible extraction; values remain unverified.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>Model withheld because a core parameter uses a library default.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>Unaccepted record; displayed values remain unverified.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>Model generation pending or unavailable; not a validation verdict.</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>Review predates the current extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>All responding readers agree on all compared fields; fractions indicate agreeing/total readers.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>At least one non-structural discrepancy or incomplete reader agreement.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>At least one structural-parameter discrepancy; primary extraction retained pending review.</td></tr><tr><td><span class="pk-badge pk-badge--species">rat</span></td><td>Non-human or in-vitro evidence; parameters and simulations describe the stated experimental system.</td></tr></tbody></table>
<p><small><b>Status</b> reports validation and review outcomes; <b>cross-check</b> reports agreement between independent extractions. Agreement does not establish plausibility, model validity, or clinical applicability.</small></p>
</details>

## Coverage

- **PubMed hits:** 3 matched, 3 returned
- **screened:** 1  ·  **relevant:** 1
- **records:** 1  ·  extracted 1  ·  needs_review 0  ·  rejected 0  ·  stale 1
- **scholar-agent fallback query used:** not captured

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Qi_2019_2 | irrelevant | 0 | 0 | The provided text is a correction notice for a clinical trial identifier and contains no pharmacokinetic data or parameters for vestronidase_alfa. |
| PD | Qi_2019_2 | not_relevant | 0 | 0 | The provided text is only a correction notice and contains no vestronidase alfa PK/PD, dose-response, concentration-effect analysis, or numeric PD parameters. |

---
<sub>Generated by `docs.py` (scholarv2) · newest extraction 2026-10-05 12:12 UTC</sub>
